Advertisement

Reactions Weekly

, Volume 1636, Issue 1, pp 279–279 | Cite as

Ribavirin/simeprevir/sofosbuvir

Colitis: case report
Case report
  • 27 Downloads

Reference

  1. Izzo I, et al. Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C. Infection 44: 811-812, No. 6, Dec 2016. Available from: URL: http://doi.org/10.1007/s15010-016-0915-x - ItalyCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations